Evidence map›Paper›PMID 41011813›Full record

ArticlePathogens (Basel, Switzerland)2025

E2 Tyrosine 102 Regulates MmuPV1 Pathogenesis In Vivo.

Jessica Gonzalez, Marsha DeSmet, Kennedy Stoll, Leny Jose, Neil Christensen, Elliot J Androphy

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jessica GonzalezDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.ORCID 0000-0001-8276-1580
Marsha DeSmetDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Kennedy StollDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Leny JoseDepartment of Dermatology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.ORCID 0000-0003-4265-251X
Neil ChristensenDepartment of Pathology, College of Medicine, Pennsylvania State University, 500 University Drive, Hershey, PA 17033, USA.
Elliot J AndrophyDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.ORCID 0000-0002-8104-0703

Funding

Immunology and Infectious Diseases Training ProgramT32AI060519 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI MARK H KAPLAN · 2004 to 2026
$6.0M
CONTROL OF PAPILLOMAVIRUS EXPRESSION AND TRANSFORMATIONR01CA058376 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ANDROPHY, ELLIOT J. · 1993 to 2019
$5.7M
Development of a mouse model to test HPV Antiviral compoundsR21AI174247 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI ANDROPHY, ELLIOT J. · 2023 to 2024
$436k
Indiana University School of Medicine Simon Comprehensive Cancer Center Tumor Microenvironment & Metastasis (TMM) N/ANCI NIH HHS R01 CA058376NIAID NIH HHS NIHR01 CA058376NIAID NIH HHS NIHT32 AI060519NIAID NIH HHS R21 AI174247NIAID NIH HHS T32 AI060519
6 · The paper itself

Abstract

The papillomavirus (PV) life cycle is strictly controlled and can be divided into the following three distinct stages: initial infection, maintenance, and amplification. The papillomavirus E2 gene encodes a multifunctional protein responsible for regulating transcription and replication by recruiting viral and host factors to the viral DNA genome. Our lab has previously reported that tyrosine 102 may impact bovine (BPV) and human (HPV) viral replication in cell culture systems. This tyrosine is conserved in the E2 protein of the murine papillomavirus MmuPV1. To investigate how this amino acid impacts the MmuPV1 lifecycle in vivo, we generated potential phosphorylation mimetic (Y102E) and phosphorylation deficient (Y102F) mutants in the E2 open reading frame. The Y102F mutant protein supported both transcriptional activation and transient replication, while Y102E was defective. However, Y102E was capable of associating with E1 and the Brd4 C-terminal motif. When these E2-mutated MmuPV1 genomes were introduced into the skin of immunocompromised mice, only Y102F was capable of inducing papilloma development and production of infectious progeny virus. These findings demonstrate that while highly conserved, tyrosine at this position is not required by the virus. These data suggest that the chemical nature of the amino acid at this position can influence E2 activity and viral replication.

Indexed as

DNA-Binding ProteinsOncogene Proteins, ViralPapillomavirus InfectionsTyrosineViral ProteinsAnimalsHumansMicePhosphorylationVirus ReplicationDNA-Binding ProteinsOncogene Proteins, ViralTyrosineViral ProteinsE2MmuPV1replicationtyrosine phosphorylation

Identifiers

PMID41011813
PMCPMC12472308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.